3537-60-8

Usage

Uses

Used in Pharmaceutical Production:
2,4,6-Trimethyl-1,3-benzenediacetic acid is used as an intermediate in the synthesis of various pharmaceuticals. Its carboxylic acid groups and methyl groups provide a versatile structure that can be further modified to create a range of drug molecules.
Used in Organic Synthesis:
2,4,6-Trimethyl-1,3-benzenediacetic acid is used as a reagent in organic synthesis. Its functional groups can participate in various chemical reactions, such as esterification, amidation, and condensation, making it a valuable building block for the creation of complex organic molecules.

Upstream product

• 87614-63-9 2,2'-(2,4,6-trimethyl-1,3-phenylene)diacetonitrile 

Relevant academic research and scientific papers

Coordination features of bis(N-heterocyclic carbenes) and bis(oxazolines) with 1,3-alkylidene-2,4,6-trimethylbenzene spacers. Synthesis of the ligands and silver and palladium complexes

The synthesis of simple imidazolium-based ligand precursors containing a 1,3-alkylidene-2,4,6-trimethylbenzene spacer was examined and different synthetic protocols were applied depending on the nature of the alkylidene arm. For a methylene arm, simple dications 5a,b·2Cl were obtained directly. The higher homologue counterparts were conveniently prepared by general multistep routes following a five-step sequence for ethylene dications 6a,b·2Br or a six-step sequence for propylene dications 7a,b·2Br in ≥ 52% overall yield. Imidazolium salts based on the shorter methylene spacer were used to prepare palladium complexes (17-20) with N-heterocyclic carbenes via transmetallation from well-defined silver compounds or directly in basic conditions. In order to facilitate spectroscopic characterisation of the palladium species two [Pd(allyl)(bis-oxazoline)]+ (25-26) complexes with the same ligand bridge were synthesized. [PdX2bisL] complexes appeared in solution as mixtures of species, mononuclear with cis- or trans-geometry or oligomeric compounds. The reaction of [PdCl(allyl)] 2 and -bis(carbene)(AgX)2 complexes in 1: 1 or in 0.5: 1 ratio leads to binuclear compounds [Pd2Cl2(allyl) 2(-bis-carbene)] (19a,19b) and to very labile monomeric [Pd(allyl)(bis-carbene)]+ (20a,20b) compounds, respectively. The preparation of analogous [Pd(allyl)(bis-oxazoline)]+ complexes showed the formation of one of the four possible isomers. [Pd(allyl)(bis-oxazoline)] PF6 complexes were inactive as catalytic precursors in the allylic substitution reaction. The Royal Society of Chemistry.